These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34391406)

  • 1. Hepatitis B vaccination coverage in Germany: systematic review.
    Steffen G; Sperle I; Harder T; Sarma N; Beermann S; Thamm R; Bremer V; Zimmermann R; Dudareva S
    BMC Infect Dis; 2021 Aug; 21(1):817. PubMed ID: 34391406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The epidemiology of Hepatitis B, C and D in Germany: A scoping review.
    Steffen G; Sperle I; Leendertz SA; Sarma N; Beermann S; Thamm R; Bremer V; Zimmermann R; Dudareva S
    PLoS One; 2020; 15(3):e0229166. PubMed ID: 32150561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus seroepidemiology data for Africa: Modelling intervention strategies based on a systematic review and meta-analysis.
    McNaughton AL; Lourenço J; Bester PA; Mokaya J; Lumley SF; Obolski U; Forde D; Maponga TG; Katumba KR; Goedhals D; Gupta S; Seeley J; Newton R; Ocama P; Matthews PC
    PLoS Med; 2020 Apr; 17(4):e1003068. PubMed ID: 32315297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing hepatitis B vaccination coverage and decreasing hepatitis B co-infection prevalence among people with HIV-1 in Germany, 1996-2019. Results from a cohort study primarily in men who have sex with men.
    Krings A; Schmidt D; Kollan C; Meixenberger K; Bannert N; Münstermann D; Tiemann C; Bremer V; Gunsenheimer-Bartmeyer B;
    HIV Med; 2024 Feb; 25(2):201-211. PubMed ID: 37786263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High level of exposure to hepatitis B virus infection in a vulnerable population of a low endemic area: A challenge for vaccination coverage.
    Weis-Torres SMDS; Fitts SMF; Cardoso WM; Higa Junior MG; Lima LA; Bandeira LM; Castro VOL; Carneiro FA; Iglecias LMM; Cesar GA; Tanaka TSO; Puga MAM; Rezende GR; Croda J; Lago BV; Motta-Castro ARC
    Int J Infect Dis; 2020 Jan; 90():46-52. PubMed ID: 31589921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. World Hepatitis day 2021 -screening and vaccination against Hepatitis B virus in Accra, Ghana.
    Kusi KA; van der Puije W; Asandem DA; Baba-Adam R; Agbevey H; Asare B; Segbefia P; Bentum-Ennin L; Annan A; Osei F; Teye-Adjei D; Galevo ES; Odame G; Ansa G; Amoah L; Bonney JHK
    BMC Public Health; 2023 Jun; 23(1):1164. PubMed ID: 37328849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Hepatitis B, C, and D in Germany: Results From a Scoping Review.
    Sperle I; Steffen G; Leendertz SA; Sarma N; Beermann S; Thamm R; Simeonova Y; Cornberg M; Wedemeyer H; Bremer V; Zimmermann R; Dudareva S
    Front Public Health; 2020; 8():424. PubMed ID: 33014960
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis B in Moroccan health care workers.
    Djeriri K; Laurichesse H; Merle JL; Charof R; Abouyoub A; Fontana L; Benchemsi N; Elharti E; El Aouad R; Chamoux A; Beytout J
    Occup Med (Lond); 2008 Sep; 58(6):419-24. PubMed ID: 18562546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of vaccine-derived hepatitis B surface antibodies in children and adolescents in Germany: results from a population-based survey, 2014-2017.
    Sperle I; Lassen SG; Schlaud M; Dörre A; Dudareva S; Poethko-Müller C; Harder T
    BMC Infect Dis; 2024 Mar; 24(1):318. PubMed ID: 38491438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. World hepatitis day in Burkina Faso, 2017: seroprevalence and vaccination against hepatitis B virus to achieve the 2030 elimination goal.
    Diarra B; Yonli AT; Ouattara AK; Zohoncon TM; Traore L; Nadembega C; Obiri-Yeboah D; Yara J; Pietra V; Ouedraogo P; Bougouma A; Sanogo R; Simpore J
    Virol J; 2018 Aug; 15(1):121. PubMed ID: 30081915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of implementation of Hepatitis B Virus (HBV) vaccination policy in household contacts of HBV carriers in Italy.
    Scognamiglio P; Girardi E; Fusco M; Piselli P; Spena SR; Maione C; Pisanti FA; Serraino D;
    BMC Infect Dis; 2009 Jun; 9():86. PubMed ID: 19500412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Full-dose hepatitis B virus vaccination coverage and associated factors among health care workers in Ethiopia: A systematic review and meta-analysis.
    Awoke N; Mulgeta H; Lolaso T; Tekalign T; Samuel S; Obsa MS; Olana R
    PLoS One; 2020; 15(10):e0241226. PubMed ID: 33108365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A large proportion of people who inject drugs are susceptible to hepatitis B: Results from a bio-behavioural study in eight German cities.
    Haussig JM; Nielsen S; Gassowski M; Bremer V; Marcus U; Wenz B; Bannert N; Bock CT; Zimmermann R;
    Int J Infect Dis; 2018 Jan; 66():5-13. PubMed ID: 29097248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cross-sectional serosurvey on hepatitis B vaccination uptake among adult patients from GP practices in a region of South-West Poland.
    Ganczak M; Dmytrzyk-Daniłów G; Korzeń M; Szych Z
    BMC Public Health; 2015 Oct; 15():1060. PubMed ID: 26475167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant reduction in notification and seroprevalence rates of hepatitis B virus infection among the population of Zhejiang Province, China, aged between 1 and 29years from 2006 to 2014.
    Zhou Y; He H; Deng X; Yan R; Tang X; Xie S; Yao J
    Vaccine; 2017 Aug; 35(34):4355-4361. PubMed ID: 28687404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B testing, care linkage, and vaccination coverage within a registry of hepatitis C infected patients.
    Harris AM; Millman AJ; Lora M; Osinubi A; Lom J; Miller LS
    Vaccine; 2019 Apr; 37(16):2188-2193. PubMed ID: 30902481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus markers among teenagers in the Araguaia region, Central Brazil: assessment of prevalence and vaccination coverage.
    Melo LV; da Silva MA; Calçada Cde O; Cavalcante SR; Souto FJ
    Vaccine; 2011 Jul; 29(32):5290-3. PubMed ID: 21605613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus in the Lao People's Democratic Republic: a cross sectional serosurvey in different cohorts.
    Black AP; Nouanthong P; Nanthavong N; Souvannaso C; Vilivong K; Jutavijittum P; Samountry B; Lütteke N; Hübschen JM; Goossens S; Quet F; Buisson Y; Muller CP
    BMC Infect Dis; 2014 Aug; 14():457. PubMed ID: 25149478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B Seroepidemiology in Australia, One Decade After Universal Vaccination of Infants and Adolescents.
    Lu X; Quinn HE; Menzies RI; Hueston L; Gilbert L; McIntyre PB
    Infect Disord Drug Targets; 2020; 20(3):341-347. PubMed ID: 30277170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.